Stay updated with breaking news from Cue Care. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good day and thank you for standing by. Welcome to the Cue Health Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
You can take a rapid molecular test at home now, which is a game-changer as fall approaches.
The healthcare technology company Cue Health Inc. (NASDAQ: HLTH) has become the first company to get De Novo authorization from the U.S.
Cue Health (Nasdaq:HLTH) announced that it received FDA de novo authorization for its Cue COVID-19 molecular test.
Cue’s COVID-19 Molecular Test detects all known variants of concern and seamlessly integrates with Cue Care, the company’s innovative test-to-treatment platform ... | June 6, 2023